Asterias Biotherapeutics, Inc. 4
4 · Asterias Biotherapeutics, Inc. · Filed Apr 3, 2017
Insider Transaction Report
Form 4
LeBuhn Richard T.
Director
Transactions
- Award
Stock Options
2017-03-30+20,000→ 20,000 totalExercise: $3.45From: 2017-03-30Exp: 2027-03-29→ Common Stock (20,000 underlying)
Footnotes (1)
- [F1]The stock options vest over four equal quarterly installments beginning on March 31, 2017, contingent upon continued service on the Board of Directors.